Literature DB >> 29194563

Cyclic analogues of α-conotoxin Vc1.1 inhibit colonic nociceptors and provide analgesia in a mouse model of chronic abdominal pain.

Joel Castro1,2, Luke Grundy1,2, Annemie Deiteren1,2, Andrea M Harrington1,2, Tracey O'Donnell1,2, Jessica Maddern1,2, Jessi Moore1,2, Sonia Garcia-Caraballo1,2, Grigori Y Rychkov2, Rilei Yu3, Quentin Kaas3, David J Craik3, David J Adams4, Stuart M Brierley1,2.   

Abstract

BACKGROUND AND
PURPOSE: Patients with irritable bowel syndrome suffer from chronic visceral pain (CVP) and limited analgesic therapeutic options are currently available. We have shown that α-conotoxin Vc1.1 induced activation of GABAB receptors on the peripheral endings of colonic afferents and reduced nociceptive signalling from the viscera. However, the analgesic efficacy of more stable, cyclized versions of Vc1.1 on CVP remains to be determined. EXPERIMENTAL APPROACH: Using ex vivo colonic afferent preparations from mice, we determined the inhibitory actions of cyclized Vc1.1 (cVc1.1) and two cVc1.1 analogues on mouse colonic nociceptors in healthy and chronic visceral hypersensitivity (CVH) states. Using whole-cell patch clamp recordings, we also assessed the inhibitory actions of these peptides on the neuronal excitability of colonic innervating dorsal root ganglion neurons. In vivo, the analgesic efficacy of these analogues was assessed by determining the visceromotor response to colorectal distension in healthy and CVH mice. KEY
RESULTS: cVc1.1 and the cVc1.1 analogues, [C2H,C8F]cVc1.1 and [N9W]cVc1.1, all caused concentration-dependent inhibition of colonic nociceptors from healthy mice. Inhibition by these peptides was greater than those evoked by linear Vc1.1 and was substantially greater in colonic nociceptors from CVH mice. cVc1.1 also reduced excitability of colonic dorsal root ganglion neurons, with greater effect in CVH neurons. CVH mice treated with cVc1.1 intra-colonically displayed reduced pain responses to noxious colorectal distension compared with vehicle-treated CVH mice. CONCLUSIONS AND IMPLICATIONS: Cyclic versions of Vc1.1 evoked significant anti-nociceptive actions in CVH states, suggesting that they could be novel candidates for treatment of CVP. LINKED ARTICLES: This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc.
© 2017 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29194563      PMCID: PMC5980271          DOI: 10.1111/bph.14115

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  60 in total

1.  The synthesis, structural characterization, and receptor specificity of the alpha-conotoxin Vc1.1.

Authors:  Richard J Clark; Harald Fischer; Simon T Nevin; David J Adams; David J Craik
Journal:  J Biol Chem       Date:  2006-06-05       Impact factor: 5.157

2.  Increased κ-opioid receptor expression and function during chronic visceral hypersensitivity.

Authors:  Patrick A Hughes; Joel Castro; Andrea M Harrington; Nicole Isaacs; Melissa Moretta; Gareth A Hicks; David M Urso; Stuart M Brierley
Journal:  Gut       Date:  2013-11-27       Impact factor: 23.059

Review 3.  Therapeutic potential of conopeptides.

Authors:  Christina I Schroeder; David J Craik
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

4.  Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.

Authors:  Rilei Yu; Shiva N Kompella; David J Adams; David J Craik; Quentin Kaas
Journal:  J Med Chem       Date:  2013-04-29       Impact factor: 7.446

5.  Activation of splanchnic and pelvic colonic afferents by bradykinin in mice.

Authors:  S M Brierley; R C W Jones; L Xu; G F Gebhart; L A Blackshaw
Journal:  Neurogastroenterol Motil       Date:  2005-12       Impact factor: 3.598

6.  Activation of GABA(B) receptors potentiates inward rectifying potassium currents in satellite glial cells from rat trigeminal ganglia: in vivo patch-clamp analysis.

Authors:  M Takeda; M Nasu; T Kanazawa; Y Shimazu
Journal:  Neuroscience       Date:  2014-12-24       Impact factor: 3.590

Review 7.  Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels.

Authors:  David J Adams; Géza Berecki
Journal:  Biochim Biophys Acta       Date:  2013-02-01

8.  Assessment of colon sensitivity by luminal distension in mice.

Authors:  Julie A Christianson; Gerald F Gebhart
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 9.  Alpha9 nicotinic acetylcholine receptors and the treatment of pain.

Authors:  J Michael McIntosh; Nathan Absalom; Mary Chebib; Ana Belén Elgoyhen; Michelle Vincler
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

Review 10.  Altered Ion Channel/Receptor Expression and Function in Extrinsic Sensory Neurons: The Cause of and Solution to Chronic Visceral Pain?

Authors:  Stuart Brierley
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

View more
  12 in total

1.  Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors.

Authors:  Peter N Huynh; Peta J Harvey; Joanna Gajewiak; David J Craik; J Michael McIntosh
Journal:  Biochem Pharmacol       Date:  2020-06-25       Impact factor: 5.858

2.  Recent advances in targeting ion channels to treat chronic pain.

Authors:  Edward B Stevens; Gary J Stephens
Journal:  Br J Pharmacol       Date:  2018-06       Impact factor: 8.739

Review 3.  Hormone-like conopeptides - new tools for pharmaceutical design.

Authors:  Ashlin Turner; Quentin Kaas; David J Craik
Journal:  RSC Med Chem       Date:  2020-09-24

4.  Peripheral GABA receptors regulate colonic afferent excitability and visceral nociception.

Authors:  Emanuel Loeza-Alcocer; Thomas P McPherson; Michael S Gold
Journal:  J Physiol       Date:  2019-06-02       Impact factor: 5.182

5.  Chronic linaclotide treatment reduces colitis-induced neuroplasticity and reverses persistent bladder dysfunction.

Authors:  Luke Grundy; Andrea M Harrington; Joel Castro; Sonia Garcia-Caraballo; Annemie Deiteren; Jessica Maddern; Grigori Y Rychkov; Pei Ge; Stefanie Peters; Robert Feil; Paul Miller; Andre Ghetti; Gerhard Hannig; Caroline B Kurtz; Inmaculada Silos-Santiago; Stuart M Brierley
Journal:  JCI Insight       Date:  2018-10-04

6.  Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome.

Authors:  Nestor N Jimenez-Vargas; Luke A Pattison; Peishen Zhao; TinaMarie Lieu; Rocco Latorre; Dane D Jensen; Joel Castro; Luigi Aurelio; Giang T Le; Bernard Flynn; Carmen Klein Herenbrink; Holly R Yeatman; Laura Edgington-Mitchell; Christopher J H Porter; Michelle L Halls; Meritxell Canals; Nicholas A Veldhuis; Daniel P Poole; Peter McLean; Gareth A Hicks; Nicole Scheff; Elyssa Chen; Aditi Bhattacharya; Brian L Schmidt; Stuart M Brierley; Stephen J Vanner; Nigel W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-16       Impact factor: 11.205

7.  On the Utility of Chemical Strategies to Improve Peptide Gut Stability.

Authors:  Thomas Kremsmayr; Aws Aljnabi; Juan B Blanco-Canosa; Hue N T Tran; Nayara Braga Emidio; Markus Muttenthaler
Journal:  J Med Chem       Date:  2022-04-14       Impact factor: 8.039

8.  Characterisation of a Novel A-Superfamily Conotoxin.

Authors:  David T Wilson; Paramjit S Bansal; David A Carter; Irina Vetter; Annette Nicke; Sébastien Dutertre; Norelle L Daly
Journal:  Biomedicines       Date:  2020-05-20

Review 9.  α-Conotoxin Peptidomimetics: Probing the Minimal Binding Motif for Effective Analgesia.

Authors:  Adam C Kennedy; Alessia Belgi; Benjamin W Husselbee; David Spanswick; Raymond S Norton; Andrea J Robinson
Journal:  Toxins (Basel)       Date:  2020-08-06       Impact factor: 4.546

Review 10.  Marine Toxins and Nociception: Potential Therapeutic Use in the Treatment of Visceral Pain Associated with Gastrointestinal Disorders.

Authors:  Andreina Baj; Michela Bistoletti; Annalisa Bosi; Elisabetta Moro; Cristina Giaroni; Francesca Crema
Journal:  Toxins (Basel)       Date:  2019-07-31       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.